VivoSense
Patient Monitoring · Clinical Trial Software
$27Mtotal raised · 3 rounds on record
1open role
$25Mlatest round · Series A · Mar 2022 · 4 yr ago
1backers · Xontogeny
Overview
VivoSense is the wearable sensor CRO for clinical trials, delivering digital endpoint infrastructure, scientific expertise, and end-to-end DHT services.
Funding and backers
Total raised
$27M
3 rounds on record
Latest round
$25M
Series A · Mar 2022 · 4 yr ago
Team
51-200
employees, estimated range
Hiring now
2
+1 posted in 30 days
Grants
$393k
1 grant · CORDIS
Backers
1
Xontogeny
The money's age
Long since its last round
56 months since the last round · and hiring
Momentum
13/100
hiring for its size
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 4, 2022
Raised a round Series A $25M · SEC Form D
Jul 1, 2020
Won a grant $393k · CORDIS
May 23, 2019
Raised a round Venture round $2M · SEC Form D
Jun 19, 2018
Launched VivoSense Releases Newest Enhanced Wearable Sensor Analysis Platform · PRNewswire
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Mar 2022 | $25M | — | SEC Form D |
| Grant | Jul 2020 | $393k | — | CORDIS |
| Venture round | May 2019 | $2M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | VivoSense, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Dudley TabakinDirectorSEC Form D
David HankeyExecutive Officer, DirectorSEC Form D
Douglas McAllisterDirectorSEC Form D
Ralf HempflingDirectorSEC Form D
Colin BowerExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
backs Harbor
backs Paradigm Health
Similar startupsby what they do, their industry and backers
For more than 25 years, Banook provides Clinical Trials Response to inhance clinical trials performances.
Harbor is clinical trial software built for compliance and designed for humans. Get better data, quicker answers, and faster submissions.
Accelerate clinical trials with AI-powered software, secure infrastructure, and expert services for faster, smarter research.
Delve combines clinical trial technology with human support to improve compliance, retention, and study execution.
Brooklyn Health is a clinical technology company that provides a platform for measuring symptoms in mental health research. Its Willis…
Qorra sits between eSource and EDC, automating data entry and query resolution in clinical trials.
Jobs
≈ $67k – $133k per year (Estimated) · Equity · Remote (United States) · 3+ years exp · Bachelor's Degree
Rest API
CI/CD
Git
AWS
Management
Agile
QA
Postman
MedTech
ISO 13485
IEC 62304
21 CFR Part 11
CAPA
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$155k
Typical range
$155k
Open positions
1
1
Jobs
Senior
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 1 | $155k | $155k |
Highest paying role
Senior Content Marketing Manager
$155k
Normalized to USD per year
Visa sponsorship
1
H-1B filings in 12 months
$173k
Median offered salary
2
Open roles in United States
Who they sponsor
Data scientists
1
In the register as VivoSense, Inc., Newport Coast, CA
Other sponsors in the same field
IQVIA 142 filings
Dassault Systemes 93 filings
Veeva Systems 80 filings
Edwards Lifesciences 45 filings
See 2 open roles Alert me
US Department of Labor · latest filing Apr 8, 2026 · Visa details by country
Growth
Hiring Momentum
28/100
Slowing
Open positions
2
0 opened / 0 closed in 30 days
ATS activity
Every ~5 hours
Today
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
QA
50% ▲
Marketing
50% ▲
People
Dudley Tabakin
Director
David Hankey
Executive Officer, Director
Douglas McAllister
Director
Ralf Hempfling
Director
Colin Bower
Executive Officer, Director
Lance Myers
Director
Peter Foster
Director
Marc Cikes
Director
Chris Garabedian
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Tech stack
Technologies named in job postings at VivoSense over the last 12 months, by layer, with the share of postings for each.
Technologies in use
12
Postings analysed
2
Stack modernity
69/100
Languages
PHP
Cloud & platforms
AWS
Postman
Developer tools
Adobe Photoshop
Git
WordPress
Rest API
Practices & domains
CAPA
CI/CD
21 CFR Part 11
IEC 62304
ISO 13485
Sign in to see how your skills match this stack
Sign In
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
XontogenyVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
可穿戴传感数据临床应用开发商VivoSense完成2500万美元A轮融资-电子工程专辑
- 此轮融资由Xontogeny VenturePXV基金和总部位于瑞士的德彪集团Debiopharm创新基金共同领投- VivoSense将继续加速可穿戴传感器数据在临床试验中的收集和使用
Read more
Report
VivoSense Raises $25M for Wearable Sensor Biomarkers to Advance Clinical Trials
VivoSense, an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data raises $25M.
Read more
Report
Report
VIVOSENSE GIBT ABSCHLUSS EINER FINANZIERUNGSRUNDE DER SERIE A UNTER DER LEITUNG VON XONTOGENY UND DEBIOPHARM ÜBER 25 MIO. US DOLLAR BEKANNT
Lausanne (ots) - Die Finanzierungsrunde wurde gemeinsam von Perceptive Xontogeny Venture (PXV) Fund und dem Schweizer Debiopharm Innovation Fund geleitet. Verfahren zur Beschleunigung der Erfassung und
Read more
Report
Vivosense collects $25M to develop digital biomarkers
Vivosense Inc. aims to improve clinical trial recruitment and outcomes by developing new digital biomarkers and clinical outcome assessments (COAs) that use data from wearable devices, a goal made a touch easier by its successful completion of a $25 milli
Read more
Report
VivoSense Awarded the NIH/NCI Grant to Aid in Cancer Research
/PRNewswire/ -- VivoSense, Inc. is proud to announce that we have been awarded an NIH/NCI Phase 1 contract to develop software enabling data integration from...
Read more
Report
PharmiWeb.com - Thank you
After twenty-five years, PharmiWeb.com is closing. A note of thanks to the pharmaceutical industry community that built it.
Read more
Report
Show more news